Elsevier Australia_Lancet


Issue link: http://digitalreprints.elsevier.com/i/542588

Contents of this Issue


Page 0 of 17

www.thelancet.com/respiratory Reprint Peer reviewed and fast-tracked to publication in 4 weeks Previously published online See www.thelancet.com for WebExtra content Copyright 2015 ELSEVIER LIMITED, 125 London Wall, London EC2Y 5AS, UK. Version verified by CrossMark See www.thelancet.com for podcast Open Access article Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials Mark T Dransfield, Jean Bourbeau, Paul W Jones, Nicola A Hanania, Donald A Mahler, Jørgen Vestbo, Andrew Wachtel, Fernando J Martinez, Frank Barnhart, Lisa Sanford, Sally Lettis, Courtney Crim, Peter M A Calverley Lancet Respir Med 2013; 1: 210–23

Articles in this issue

Links on this page

view archives of Elsevier Australia_Lancet - Dransfield_120_0717